首页 | 本学科首页   官方微博 | 高级检索  
检索        

银屑灵片治疗寻常型银屑病的临床观察
引用本文:王蕾,黄咏菁,王敏华.银屑灵片治疗寻常型银屑病的临床观察[J].广州中医药大学学报,2009,26(6):520-522,525.
作者姓名:王蕾  黄咏菁  王敏华
作者单位:广州中医药大学第二附属医院皮肤科,广东,广州,510120
基金项目:广东省中医药管理局科研课题 
摘    要:目的]观察中药制剂银屑灵片治疗寻常型银屑病的临床疗效.方法]将纳入研究的48例寻常型银屑病患者,按随机化原则分为对照组和治疗组各24例.治疗组给予口服银屑灵片(由生地黄、当归、赤芍、川芎、紫草、莪术、金粟兰、土茯苓、乌梅、甘草等组成)治疗,对照组给予口服阿维A胶囊治疗,同时两组均外用本院制剂肤必润.两组均以4周为1个疗程,共治疗2个疗程.参照银屑病患者皮损程度评分(PASI)比较两组的临床疗效,并记录药物不良反应,检测血清干扰素-γ(IFN-γ)水平.结果](1)第1疗程(4周)后,两组疗效比较差异有显著性意义(P<0.05),提示阿维A胶囊起效较银屑灵片快;第2疗程(8周)后,两组疗效比较差异无显著性意义(P>0.05),说明两组长期疗效相仿.(2)治疗4周后,两组患者血清IFN-γ水平均有显著性降低(与治疗前比较,P<0.05),治疗前后差值比较差异也有显著性意义(P<0.05).治疗8周后,两组患者血清IFN-γ水平下降更显著(与治疗前比较,P<0.01),但治疗前后差值比较差异无显著性意义(P>0.05).(3)两组在皮肤干燥、腹部不适、唇干、肝肾功能异常等不良反应方面差异均有显著性意义(P<0.05或P<0.01),提示银屑灵片的副作用较阿维A胶囊少.结论]银屑灵片治疗寻常型银屑病的疗效与阿维A胶囊相仿,但副作用较阿维A胶囊少.其作用机制可能与银屑灵片能降低患者血清IFN-γ水平有关.

关 键 词:银屑病/中药疗法  银屑灵/治疗应用  干扰素-γ/血液

Clinical Observation of Yinxieling Tablets for the Treatment of Psoriasis Vulgaris
WANG Lei,HUANG Yongjing,WANG Minhua.Clinical Observation of Yinxieling Tablets for the Treatment of Psoriasis Vulgaris[J].Journal of Guangzhou University of Traditional Chinese Medicine,2009,26(6):520-522,525.
Authors:WANG Lei  HUANG Yongjing  WANG Minhua
Institution:WANG Lei,HUANG Yongjing,WANG Minhua(Dept.of Dermatology,the Second Affiliated Hospital,Guangzhou University of TCM,Guangzhou 510120 Guangdong,China)
Abstract:Objective To observe the efficacy of Yinxieling Tablets(YT) for the treatment of psoriasis vulgaris(PV),and to explore its therapeutic mechanism.Methods Forty-eight PV patients were equally randomized into two groups.The two groups received external application of Fubirun ointment.Additionally,the treatment group received oral use of YT(mainly composed of Radix Rehmanniae,Radix Angelicae Sinensis,Radix Paeoniae Rubra,Rhizoma Chuanxiong,Radix Arnebiae seu Lithospermi,Rhizoma Curcumae,Herba Chloranthi Spicati...
Keywords:PSORIASIS VULGARIS/TCD therapy  YINXIELING TABLETS/therapeutic use  INTERFERON-GAMMA/blood  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号